- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- August 2022
- 66 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- November 2021
- 620 Pages
Global
From €3640EUR$4,000USD£3,121GBP
The Rotavirus Drug market is a subset of the larger Infectious Diseases Drugs market. Rotavirus is a virus that causes severe diarrhea, vomiting, fever, and abdominal pain in infants and young children. Rotavirus is the most common cause of severe diarrhea in young children, and is responsible for the deaths of hundreds of thousands of children each year. Vaccines are the most effective way to prevent rotavirus infection, but there are also several drugs available to treat the infection. These drugs work by targeting the virus itself, or by reducing the symptoms of the infection.
The Rotavirus Drug market is highly competitive, with several major players offering a range of products. Companies in the market include Merck, GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more